Cytokinetics | CYTK - Assets


Cytokinetics reported $1.42B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Amgen USD 90.59B 445M Dec/2025
Arca Biopharma USD 509.25M 151.83M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.44B 232M Dec/2025
Brainstorm Cell Therapeutics USD 1.38M 1.19M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Capricor Therapeutics USD 126.44M 7.13M Sep/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Exelixis USD 2.84B 20.87M Dec/2025
Geron USD 567.38M 12.18M Sep/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Ligand Pharmaceuticals USD 1.48B 528.17M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025